A Study to Measure the Degree and Effectiveness of the Various vSculpt Operating Modes

NCT ID: NCT02856490

Last Updated: 2021-11-24

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

6 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-07-31

Study Completion Date

2016-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A pilot study to determine the degree and effectiveness of the various modes of vSculpt, an over-the-counter "OTC" medical device, on enhanced genital blood flow and improvement in quality of life in menopausal women who suffer sexual dysfunction and stress incontinence

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The primary aim of this study is to determine the degree and effectiveness of the various modes of vSculpt on enhanced genital blood flow with menopausal women who experience sexual dysfunction and stress incontinence as measured by temperature change in the genitalia immediately after initial and final treatment and an improvement in quality of life after using the vSculpt device over the course of four weeks. The secondary aim is to compare the differences in genital blood flow and improvement in quality of life of vSculpt's various modes against Intone, another over-the-counter "OTC" medical device that utilizes a different technology to treat stress incontinence and improve sexual dysfunction.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sexual Dysfunction Stress Incontinence

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

vSculpt with Vibration Only

vSculpt genital device used in vibration mode only.

Group Type ACTIVE_COMPARATOR

vSculpt

Intervention Type DEVICE

A genital vibration device that operates in two modes, vibration only or vibration and light, to help tone and tighten pelvic floor muscles.

vSculpt with Vibration and Light

vSculpt genital device used in vibration and light mode.

Group Type ACTIVE_COMPARATOR

vSculpt

Intervention Type DEVICE

A genital vibration device that operates in two modes, vibration only or vibration and light, to help tone and tighten pelvic floor muscles.

InTone Device

InTone genital device using electric muscle stimulation only.

Group Type ACTIVE_COMPARATOR

InTone

Intervention Type DEVICE

A genital device using electric muscle stimulation to treat incontinence.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

vSculpt

A genital vibration device that operates in two modes, vibration only or vibration and light, to help tone and tighten pelvic floor muscles.

Intervention Type DEVICE

InTone

A genital device using electric muscle stimulation to treat incontinence.

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

ApexM

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Study participants will be female
* Female participants who are capable of giving informed consent
* Female participants who are menopausal who have not had a menses within one year, and are within the ages of 48 and 60
* Female participants who have had one or more vaginal births
* Female participants who are currently engaged in vaginal sexual intercourse with a partner
* Female participants who are presently experiencing bladder control issues either leakage, frequency or urgency
* Female participants who are presently experiencing pain during sexual intercourse

Exclusion Criteria

* Female participants shall not have an active sexually transmitted disease and/or infection
* Female participants who are actively undergoing chemotherapy
* Female participants who are currently taking any cancer-related drugs
* Female participants who are breastfeeding or lactating
* Female participants who have a medical history of neurological disorders (e.g., multiple sclerosis, Parkinson's disease)
* Female participants with an active urinary tract infection (UTI)
* Female participants with active bladder stones
* Female participants with active bladder tumor(s)
* Females with prior laser or vaginal rejuvenation surgeries or treatments
* Females with a medical history of vaginal cancer or radiation or surgery with exception of related to childbirth
* Females with prior non-invasive treatments (estrogen cream) or pelvic floor physical therapy for the vaginal area/ pelvic floor in the past six month
* Females with a physical disability precluding her from holding a lithotomy for an hour
* Females who are homeless
Minimum Eligible Age

48 Years

Maximum Eligible Age

60 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Joylux, Inc.

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

San Diego Sexual Medicine

San Diego, California, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

JOY 1515-02

Identifier Type: -

Identifier Source: org_study_id